Save your place

Sign in to WhoBought

Please try again later.

Jeremy Grantham's Amicus Therapeutics, Inc. (FOLD) position

Yes: as of Q1 2026, Jeremy Grantham holds 941K shares of FOLD worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was opened. First disclosed Q1 2026.
View full portfolio →
Current value
an amount we cannot price
Shares held
941K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

FOLD price vs Grantham's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 New +941K 941K May 14, 2026
Data through Q1 2026 · filed May 14, 2026
1 grouped rows from 1 quarters

More Grantham positions

Common questions

Does Jeremy Grantham own FOLD?

Yes. As of Q1 2026, Jeremy Grantham disclosed 941K shares of FOLD, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jeremy Grantham buy FOLD?

Jeremy Grantham first disclosed a FOLD position in Q1 2026; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jeremy Grantham sell FOLD?

The quarter-by-quarter table above shows each sale and reduction Jeremy Grantham disclosed in FOLD. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of FOLD does Jeremy Grantham own?

Jeremy Grantham disclosed 941K shares of FOLD as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jeremy Grantham pay for FOLD?

Jeremy Grantham began building the FOLD position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.